AstraZeneca has agreed to pay $425 million over 11,000 claims the heartburn drugs Nexium and Prilosec caused chronic kidney disease. AstraZeneca has agreed to pay $425 million to settle lawsuits ...

Britain's AstraZeneca has agreed to pay $425 million to settle about 11,000 lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease.

AstraZeneca settles heartburn drug lawsuits for $425mn on whatsapp (opens in a new window) Save Donato Paolo Mancini in London. Published October 3 2023. Jump to comments section Print this page.

AstraZeneca AZN announced that it has entered into settlement agreements for pending litigations related to its proton pump inhibitors (PPIs), Nexium and Prilosec, for $425 million. Higher-dose ...

AstraZeneca Pharmaceuticals agreed to pay $425 million to settle lawsuits from about 11,000 consumers alleging they suffered kidney injuries after taking Nexium and Prilosec.

Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec ...

Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of scheming to delay a generic version of its schizophrenia drug Seroquel ...

Here are 10 recent healthcare industry lawsuits, ... Calif.-based Sutter Health agreed to pay $228.5 million to settle a long-running class action lawsuit alleging ... AbbVie and AstraZeneca, ...

AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...